Two insiders selling at Canopy Growth (WEED)

Two insiders selling at Canopy Growth (T:WEED)

Timothy Rob Saunders, CFO, exercised Options and disposed of 149,999 Common Shares on a direct ownership basis at prices ranging from $18.539 to $18.544 between November 21st and 22nd, 2017. This represents a $2,781,424 divestment of the company's shares and an account share holdings change of -100.0%.

Christopher James Schnarr, a Director, also exercised Options and sold 50,000 Common Shares on a direct ownership basis at $19.03 on November 24th, 2017.

Canopy Growth is in the Pharmaceuticals Sub Industry Group under the Healthcare Sector.

Canopy Growth Corporation, formerly Tweed Marijuana Inc., is a diversified cannabis company. The Company, through its subsidiaries Tweed Inc. (Tweed), Bedrocan Canada Inc. (Bedrocan) and Tweed Farms Inc. (Tweed Farms), is engaged in the business of producing and selling legal marijuana in the Canadian medical market. It is also focusing on producing and selling marijuana in the recreational market in Canada. Its core brands are Tweed and Bedrocan. Tweed is a licensed producer of medical marijuana. Tweed's commercial license covers approximately 168,000 square feet of its Smiths Falls facility and allows Tweed to produce and sell approximately 3,540 kilograms of medical marijuana per year. Tweed's built-out production capacity is over 10 climate controlled indoor growing rooms. Bedrocan is a medical-grade cannabis. Bedrocan's over 52,000 square feet production facility in Toronto, Ontario is licensed, and includes over 30 vegetative and growing rooms, and over three dispensing rooms.